Skip to main content

Table 2 Natural products against hematogical malignancies in clinical trials

From: Role of Non Receptor Tyrosine Kinases in Hematological Malignances and its Targeting by Natural Products

NATURAL PRODUCTS

CANCER TYPE

STATUS

STUDY PHASE

Clinical trials.gov number

Homoharringtonine

CML

COMPLETED

PHASE 2

NCT00375219 (a)

Tanespimycin (17-AAG)

AML

COMPLETED

PHASE 1

NCT00098423 (b)

  1. a https://clinicaltrials.gov/ct2/show/record/NCT00375219?term=omacetaxine&cond=LEUKEMIA&draw=1&rank=2
  2. b https://clinicaltrials.gov/ct2/show/NCT00098423?term=17-AAG&cond=Leukemia&draw=1&rank=6
Back to article page

Molecular Cancer

ISSN: 1476-4598